Neurobiology of Aging
Volume 30, Issue 10 , Pages 1545-1551 , October 2009

APOE-related mortality: Effect of dementia, cardiovascular disease and gender

  • Lina Rosvall

      Affiliations

    • Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, SE-11330, Stockholm, Sweden
    • Karolinska Institutet, Department NVS, KI-Alzheimer Disease Research Center, SE-14186, Stockholm, Sweden
    • The authors contributed equally to this work.
    • Corresponding Author InformationCorresponding author at: KI Alzheimer Disease Research Center, Department of Neurobiology, Health Care Sciences and Society, Karolinska Institutet, Novum 5th Floor, Karolinska University Hospital, 14157 Huddinge, Sweden. Tel.: +46 8 5858 36 01; fax: +46 8 5858 36 45.
    • ,
  • Debora Rizzuto

      Affiliations

    • Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, SE-11330, Stockholm, Sweden
    • The authors contributed equally to this work.
    • ,
  • Hui-Xin Wang

      Affiliations

    • Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, SE-11330, Stockholm, Sweden
    • ,
  • Bengt Winblad

      Affiliations

    • Karolinska Institutet, Department NVS, KI-Alzheimer Disease Research Center, SE-14186, Stockholm, Sweden
    • ,
  • Caroline Graff

      Affiliations

    • Karolinska Institutet, Department NVS, KI-Alzheimer Disease Research Center, SE-14186, Stockholm, Sweden
    • ,
  • Laura Fratiglioni

      Affiliations

    • Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, SE-11330, Stockholm, Sweden

Received 15 October 2007 ,Revised 3 December 2007 ,Accepted 5 December 2007.

References 

  1. American Psychiatric Association (A.P.) . Diagnostic and Statistical Manual of Mantal Disorders. Washington, DC: American Psychiatric Association; 1987;
  2. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, et al. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke. 1996;27:1310–1315
  3. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 1994;24:471–476
  4. Cleves MA, Gould WW, Gutierrez RG. An Introduction to Survival Analysis using Stata. Texas: Stata Press; 2004;
  5. Commenges D, Letenneur L, Joly P, Alioum A, Dartigues JF. Modelling age-specific risk: application to dementia. Stat Med. 1998;17:1973–1988
  6. Corder EH, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winblad B, et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch. Neurol. 1996;53:418–422
  7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923
  8. Dal Forno G, Carson KA, Brookmeyer R, Troncoso J, Kawas CH, Brandt J. APOE genotype and survival in men and women with Alzheimer's disease. Neurology. 2002;58:1045–1050
  9. Davignon J. Apolipoprotein E and atherosclerosis: beyond lipid effect. Arterioscler. Thromb. Vasc. Biol. 2005;25:267–269
  10. Eskes T, Haanen C. Why do women live longer than men?. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007;133:126–133
  11. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet. Epidemiol. 2002;22:146–155
  12. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349–1356
  13. Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ. 1994;309:1202–1206
  14. Fratiglioni L, Viitanen M, Backman L, Sandman PO, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology. 1992;11(Suppl. 1):29–36
  15. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48:132–138
  16. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J. Gerontol. A: Biol. Sci. Med. Sci. 2001;56:M75–M78
  17. Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, Khachaturian AS, et al. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J. Am. Geriatr. Soc. 2005;53:935–942
  18. Heijmans BT, Westendorp RG, Slagboom PE. Common gene variants, mortality and extreme longevity in humans. Exp. Gerontol. 2000;35:865–877
  19. Hjelmborg JV, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M, et al. Genetic influence on human lifespan and longevity. Hum. Genet. 2006;119:312–321
  20. Iachine IA, Holm NV, Harris JR, Begun AZ, Iachina MK, Laitinen M, et al. How heritable is individual susceptibility to death? The results of an analysis of survival data on Danish. Swedish and Finnish twins. Twin Res. 1998;1:196–205
  21. Koivisto AM, Lempiainen P, Koivisto K, Helkala EL, Mykkanen L, Kuusisto J, et al. Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study. Neuroepidemiology. 2000;19:327–332
  22. Lahiri DK. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene. J. Mol. Neurosci. 2004;23:225–233
  23. Lewis SJ, Brunner EJ. Methodological problems in genetic association studies of longevity—the apolipoprotein E gene as an example. Int. J. Epidemiol. 2004;33:962–970
  24. Louhija J, Miettinen HE, Kontula K, Tikkanen MJ, Miettinen TA, Tilvis RS. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler. Thromb. 1994;14:1084–1089
  25. Louhija J, Viitanen M, Aguero-Torres H, Tilvis R. Survival in Finnish centenarians in relation to apolipoprotein E polymorphism. J. Am. Geriatr. Soc. 2001;49:1007–1008
  26. Lunenfeld B. The ageing male: demographics and challenges. World J. Urol. 2002;20:11–16
  27. Mattila KM, Axelman K, Rinne JO, Blomberg M, Lehtimaki T, Laippala P, et al. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci. Lett. 2000;282:45–48
  28. Porrello E, Monti MC, Sinforiani E, Cairati M, Guaita A, Montomoli C, et al. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur. J. Neurol. 2006;13:639–644
  29. Raiha I, Marniemi J, Puukka P, Toikka T, Ehnholm C, Sourander L. Effect of serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascular mortality in the elderly. Arterioscler. Thromb. Vasc. Biol. 1997;17:1224–1232
  30. Royston P. Multiple imputation of missing values. Stata J. 2004;4:227–241
  31. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 1994;6:29–32
  32. Seripa D, Franceschi M, Matera MG, Panza F, Kehoe PG, Gravina C, et al. Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy. J. Gerontol. A: Biol. Sci. Med. Sci. 2006;61:918–923
  33. Skoog I, Hesse C, Aevarsson O, Landahl S, Wahlstrom J, Fredman P, et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J. Neurol. Neurosurg. Psychiatry. 1998;64:37–43
  34. Slooter AJ, Cruts M, Van Broeckhoven C, Hofman A, van Duijin CM. Apolipoprotein E and longevity: the Rotterdam Study. J. Am. Geriatr. Soc. 2001;49:1258–1259
  35. Stengard JH, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Genotypes with the apolipoprotein epsilon4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Hum. Genet. 1996;97:677–684
  36. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995;91:265–269
  37. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576–582
  38. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J. Am. Geriatr. Soc. 1998;46:712–715
  39. Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum. Genet. 1984;65:237–241
  40. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat. Med. 1999;18(6):681–694
  41. Vogt MT, Cauley JA, Kuller LH. Apolipoprotein E phenotype, arterial disease, and mortality among older women: the study of osteoporotic fractures. Genet. Epidemiol. 1997;14:147–156
  42. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA. 1994;272:1666–1671

PII: S0197-4580(07)00468-X

doi: 10.1016/j.neurobiolaging.2007.12.003

Neurobiology of Aging
Volume 30, Issue 10 , Pages 1545-1551 , October 2009

Article Tools

* Image Usage & Resolution